Bacteremia in HIV-infected children under 5 years old hospitalized in Mozambique
莫桑比克住院的5岁以下感染艾滋病毒的儿童出现菌血症
基本信息
- 批准号:9306755
- 负责人:
- 金额:$ 14.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-22 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:5 year oldAcquired Immunodeficiency SyndromeAcute respiratory infectionAdmission activityAdultAfricaAfrica South of the SaharaAfricanAnemiaAntibiotic susceptibilityAntibioticsBacteremiaBacteriaBacterial InfectionsBloodCase Fatality RatesCessation of lifeChildCitiesClinicalCountryDataDiarrheaDiseaseEscherichia coliEtiologyExhibitsFecesFeverFormulariesFrequenciesGastroenteritisGenomicsGeographic LocationsHIVHaemophilus influenzaeHealth systemHealthcareHigh PrevalenceHospitalsHumanIncidenceIncomeInfectionInstitutionInterventionLive BirthMalariaMalnutritionMicrobiologyMolecularMoonMozambiqueObservational StudyOrganismOutcomePathogenicityPatternPediatric HospitalsPharmaceutical PreparationsPhylogenetic AnalysisPopulationPredispositionPrevalenceProvincePublic HealthRecurrenceReportingResearchResearch InfrastructureResistanceResource AllocationResourcesRuralSalmonellaSalmonella entericaSalmonella typhimuriumSamplingSepsisSerotypingServicesStaphylococcus aureusStreptococcus pneumoniaeTestingUniversitiesUrban HealthWorkagedbaseburden of illnessgeographic differencehealth differencehealth disparitymortalitymultidisciplinarypathogenpediatric AIDSprospectivepublic health relevancerural arearural settingurban areaurban setting
项目摘要
DESCRIPTION (provided by applicant): Every year 4.6 million children <5 years of age (U5) die in sub-Saharan Africa. Incidence of disease for infections such as malaria, acute respiratory infection (ARI), diarrhea and human immunodeficiency virus (HIV) have been described. Existing estimates as to the incidence, mortality, or hospital burden of most pathogenic bacterial infections is predominantly limited to urban areas, thus the impact of U5 bacteremia is largely unknown as most people live in rural areas. Early studies suggest bacteremia in hospitalized African children exceeds that of high income countries and that gram-negative organisms, in particular non-typhoidal salmonella (NTS) are among the most common isolates, especially where the prevalence of HIV and malaria is high. The incidence of invasive NTS disease in Africa has been estimated at between 175-388 cases per 100,000 children aged 3-5 years. There are important differences by geographic region in U5 mortality, with the northern provinces having the highest rates respectively. Mozambique also has important urban/rural differences in health outcomes. U5 mortality in 2009 was estimated at 135/1000 live births in urban areas compared to 162/1000 live births in rural areas with higher frequency of death occurring in rural areas for each of the three main killers in children. We will conduct a prospective hospital-based observational study of HIV-infected children <5 years old, hospitalized with fever to determine the incidence, etiology, and antibiotic sensitivity patterns o culture confirmed bacteremia in representative rural and urban settings. The study will take place at Hospital Mavalane in Maputo city and the Quelimane Provincial Hospital in the Province of Zambezia, Mozambique. Our specific aims include: 1) To test the hypothesis that the incidence of bacteremia in HIV-infected children U5, hospitalized with fever is higher in children living in rural areas (Zambezia Province) compared with those living in urban areas (Maputo City); and 2) To test the hypothesis that non-typhoidal salmonella (NTS) is a major cause of bacteremia in HIV-infected children U5, hospitalized with fever in both urban Maputo City and rural Zambezia Province, Mozambique. Additionally, we will further genetically characterize NTS samples in blood and stool for the presence of the invasive ST313 strain. To accomplish these aims we have assembled a strong multidisciplinary team representing University Eduardo Mondlane (UEM) and Vanderbilt University and supported by the strong research and service infrastructures of these two major institutions. Our study holds promise to illuminate rural/urban health disparities that can then be targeted for mitigation. The results of this project will also provide crucial but currently unavailable information needed to prioritize resource allocation for microbiology capacity and guide national drug formulary practices.
描述(由申请人提供):在撒哈拉以南非洲,每年有460万5岁以下儿童死亡。疟疾、急性呼吸道感染、腹泻和人类免疫缺陷病毒(艾滋病毒)等传染病的发病率已得到描述。关于大多数病原性细菌感染的发病率、死亡率或医院负担的现有估计主要限于城市地区,因此,由于大多数人生活在农村地区,U 5菌血症的影响在很大程度上是未知的。早期的研究表明,非洲住院儿童的菌血症超过了高收入国家,革兰氏阴性菌,特别是非伤寒沙门氏菌(NTS)是最常见的分离株,特别是在艾滋病毒和疟疾流行率高的地方。据估计,非洲侵袭性NTS疾病的发病率为每10万名3-5岁儿童175-388例。五岁以下儿童死亡率在各地理区域之间有很大差异,北方各省的死亡率最高。莫桑比克在保健成果方面也存在着重大的城乡差别。2009年,城市地区5岁以下儿童死亡率估计为135/1,000活产,而农村地区为162/1,000活产,农村地区儿童三大主要杀手的死亡率更高。我们将对5岁以下因发热住院的HIV感染儿童进行一项前瞻性医院观察性研究,以确定在代表性农村和城市环境中培养证实的菌血症的发病率、病因和抗生素敏感性模式。这项研究将在马普托市的马瓦兰医院和莫桑比克赞比西亚省的克利马内省医院进行。我们的具体目标包括:1)检验以下假设:在农村地区,因发热住院的艾滋病毒感染儿童U 5的菌血症发病率较高(赞比西亚省)与城市地区相比(马普托市);和2)为了检验非伤寒沙门氏菌(NTS)是HIV感染儿童U 5菌血症的主要原因的假设,莫桑比克马普托市和赞比西亚省农村因发烧住院。此外,我们将进一步对血液和粪便中的NTS样本进行遗传表征,以确定是否存在侵袭性ST 313菌株。为了实现这些目标,我们组建了一支强大的多学科团队,代表Eduardo Mondlane大学(UEM)和范德比尔特大学,并得到这两个主要机构强大的研究和服务基础设施的支持。我们的研究有望阐明农村/城市的健康差距,然后可以针对缓解。该项目的结果还将提供目前无法获得的重要信息,以便优先为微生物学能力分配资源,并指导国家药物处方做法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
D. Troy Moon其他文献
D. Troy Moon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('D. Troy Moon', 18)}}的其他基金
UEM-Partnership for Research in Implementation Science Mozambique (PRISM).
UEM-莫桑比克实施科学研究伙伴关系(PRISM)。
- 批准号:
10755775 - 财政年份:2023
- 资助金额:
$ 14.84万 - 项目类别:
Partnership for Research in Emerginig Viral Infections-Sierra Leone (PREVSL)
塞拉利昂新兴病毒感染研究伙伴关系 (PREVSL)
- 批准号:
10613425 - 财政年份:2023
- 资助金额:
$ 14.84万 - 项目类别:
Academic Partnership for Enhancements in Research (APER)
增强研究学术合作伙伴关系 (APER)
- 批准号:
10752791 - 财政年份:2023
- 资助金额:
$ 14.84万 - 项目类别:
Partnership for Research in Emerginig Viral Infections-Sierra Leone (PREVSL)
塞拉利昂新兴病毒感染研究伙伴关系 (PREVSL)
- 批准号:
10754357 - 财政年份:2023
- 资助金额:
$ 14.84万 - 项目类别:
West Africa - Tulane University Laboratory Training Fellowship Supplement for Partnership for Research in Emerging Viral Infections Sierra Leone (PREVSL) U2RTW011248
西非 - 杜兰大学实验室培训奖学金补充塞拉利昂新发病毒感染研究伙伴关系 (PREVSL) U2RTW011248
- 批准号:
10876594 - 财政年份:2023
- 资助金额:
$ 14.84万 - 项目类别:
UEM-Vanderbilt Academic Partnership for Enhancements in Research (APER)
UEM-范德堡大学研究增强学术合作伙伴关系 (APER)
- 批准号:
10259747 - 财政年份:2020
- 资助金额:
$ 14.84万 - 项目类别:
UEM-Vanderbilt Academic Partnership for Enhancements in Research (APER)
UEM-范德堡大学研究增强学术合作伙伴关系 (APER)
- 批准号:
10400635 - 财政年份:2020
- 资助金额:
$ 14.84万 - 项目类别:
UEM Partnership for Research in Implementation Science Mozambique (PRISM)
UEM 莫桑比克实施科学研究合作伙伴关系 (PRISM)
- 批准号:
9301949 - 财政年份:2015
- 资助金额:
$ 14.84万 - 项目类别:
UEM-Vanderbilt Partnership for Research in Implementation Science Mozambique (PRISM)
UEM-范德比尔特莫桑比克实施科学研究合作伙伴关系 (PRISM)
- 批准号:
10347355 - 财政年份:2015
- 资助金额:
$ 14.84万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 14.84万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 14.84万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 14.84万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 14.84万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 14.84万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 14.84万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 14.84万 - 项目类别:














{{item.name}}会员




